249 related articles for article (PubMed ID: 12397398)
1. Optimal absorptive transport of the dipeptide glycylsarcosine is dependent on functional Na+/H+ exchange activity.
Kennedy DJ; Leibach FH; Ganapathy V; Thwaites DT
Pflugers Arch; 2002 Oct; 445(1):139-46. PubMed ID: 12397398
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of intestinal dipeptide transport by the neuropeptide VIP is an anti-absorptive effect via the VPAC1 receptor in a human enterocyte-like cell line (Caco-2).
Anderson CM; Mendoza ME; Kennedy DJ; Raldua D; Thwaites DT
Br J Pharmacol; 2003 Feb; 138(4):564-73. PubMed ID: 12598410
[TBL] [Abstract][Full Text] [Related]
3. H/dipeptide absorption across the human intestinal epithelium is controlled indirectly via a functional Na/H exchanger.
Thwaites DT; Kennedy DJ; Raldua D; Anderson CM; Mendoza ME; Bladen CL; Simmons NL
Gastroenterology; 2002 May; 122(5):1322-33. PubMed ID: 11984519
[TBL] [Abstract][Full Text] [Related]
4. Indirect regulation of the intestinal H+-coupled amino acid transporter hPAT1 (SLC36A1).
Anderson CM; Thwaites DT
J Cell Physiol; 2005 Aug; 204(2):604-13. PubMed ID: 15754324
[TBL] [Abstract][Full Text] [Related]
5. Regulation of intestinal hPepT1 (SLC15A1) activity by phosphodiesterase inhibitors is via inhibition of NHE3 (SLC9A3).
Anderson CM; Thwaites DT
Biochim Biophys Acta; 2007 Jul; 1768(7):1822-9. PubMed ID: 17498647
[TBL] [Abstract][Full Text] [Related]
6. Interactions of a nonpeptidic drug, valacyclovir, with the human intestinal peptide transporter (hPEPT1) expressed in a mammalian cell line.
Guo A; Hu P; Balimane PV; Leibach FH; Sinko PJ
J Pharmacol Exp Ther; 1999 Apr; 289(1):448-54. PubMed ID: 10087037
[TBL] [Abstract][Full Text] [Related]
7. Interactions of the dipeptide ester prodrugs of acyclovir with the intestinal oligopeptide transporter: competitive inhibition of glycylsarcosine transport in human intestinal cell line-Caco-2.
Anand BS; Patel J; Mitra AK
J Pharmacol Exp Ther; 2003 Feb; 304(2):781-91. PubMed ID: 12538834
[TBL] [Abstract][Full Text] [Related]
8. The bioactive dipeptide anserine is transported by human proton-coupled peptide transporters.
Geissler S; Zwarg M; Knütter I; Markwardt F; Brandsch M
FEBS J; 2010 Feb; 277(3):790-5. PubMed ID: 20067523
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor and insulin short-term increase hPepT1-mediated glycylsarcosine uptake in Caco-2 cells.
Nielsen CU; Amstrup J; Nielsen R; Steffansen B; Frokjaer S; Brodin B
Acta Physiol Scand; 2003 Jun; 178(2):139-48. PubMed ID: 12780388
[TBL] [Abstract][Full Text] [Related]
10. Transport characteristics of differently charged cephalosporin antibiotics in oocytes expressing the cloned intestinal peptide transporter PepT1 and in human intestinal Caco-2 cells.
Wenzel U; Gebert I; Weintraut H; Weber WM; Clauss W; Daniel H
J Pharmacol Exp Ther; 1996 May; 277(2):831-9. PubMed ID: 8627565
[TBL] [Abstract][Full Text] [Related]
11. Dual modes of 5-(N-ethyl-N-isopropyl)amiloride modulation of apical dipeptide uptake in the human small intestinal epithelial cell line Caco-2.
Kennedy DJ; Raldua D; Thwaites DT
Cell Mol Life Sci; 2005 Jul; 62(14):1621-31. PubMed ID: 15968466
[TBL] [Abstract][Full Text] [Related]
12. The apical (hPepT1) and basolateral peptide transport systems of Caco-2 cells are regulated by AMP-activated protein kinase.
Pieri M; Christian HC; Wilkins RJ; Boyd CA; Meredith D
Am J Physiol Gastrointest Liver Physiol; 2010 Jul; 299(1):G136-43. PubMed ID: 20430871
[TBL] [Abstract][Full Text] [Related]
13. Direct evidence for peptide transporter (PepT1)-mediated uptake of a nonpeptide prodrug, valacyclovir.
Balimane PV; Tamai I; Guo A; Nakanishi T; Kitada H; Leibach FH; Tsuji A; Sinko PJ
Biochem Biophys Res Commun; 1998 Sep; 250(2):246-51. PubMed ID: 9753615
[TBL] [Abstract][Full Text] [Related]
14. hPepT1-mediated epithelial transport of bacteria-derived chemotactic peptides enhances neutrophil-epithelial interactions.
Merlin D; Steel A; Gewirtz AT; Si-Tahar M; Hediger MA; Madara JL
J Clin Invest; 1998 Dec; 102(11):2011-8. PubMed ID: 9835627
[TBL] [Abstract][Full Text] [Related]
15. Transport of the advanced glycation end products alanylpyrraline and pyrralylalanine by the human proton-coupled peptide transporter hPEPT1.
Geissler S; Hellwig M; Zwarg M; Markwardt F; Henle T; Brandsch M
J Agric Food Chem; 2010 Feb; 58(4):2543-7. PubMed ID: 20104847
[TBL] [Abstract][Full Text] [Related]
16. High-affinity interaction of sartans with H+/peptide transporters.
Knütter I; Kottra G; Fischer W; Daniel H; Brandsch M
Drug Metab Dispos; 2009 Jan; 37(1):143-9. PubMed ID: 18824524
[TBL] [Abstract][Full Text] [Related]
17. Transport and uptake of nateglinide in Caco-2 cells and its inhibitory effect on human monocarboxylate transporter MCT1.
Okamura A; Emoto A; Koyabu N; Ohtani H; Sawada Y
Br J Pharmacol; 2002 Oct; 137(3):391-9. PubMed ID: 12237260
[TBL] [Abstract][Full Text] [Related]
18. Correlation between epithelial cell permeability of cephalexin and expression of intestinal oligopeptide transporter.
Chu XY; Sánchez-Castaño GP; Higaki K; Oh DM; Hsu CP; Amidon GL
J Pharmacol Exp Ther; 2001 Nov; 299(2):575-82. PubMed ID: 11602669
[TBL] [Abstract][Full Text] [Related]
19. H+-zwitterionic amino acid symport at the brush-border membrane of human intestinal epithelial (CACO-2) cells.
Thwaites DT; Stevens BC
Exp Physiol; 1999 Mar; 84(2):275-84. PubMed ID: 10226170
[TBL] [Abstract][Full Text] [Related]
20. Function and immunolocalization of overexpressed human intestinal H+/peptide cotransporter in adenovirus-transduced Caco-2 cells.
Hsu CP; Walter E; Merkle HP; Rothen-Rutishauser B; Wunderli-Allenspach H; Hilfinger JM; Amidon GL
AAPS PharmSci; 1999; 1(3):E12. PubMed ID: 11741208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
